These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22221838)

  • 21. Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period.
    Rizzo C; Rota MC; Bella A; Alfonsi V; Declich S; Caporali MG; Ranghiasci A; Lapini G; Piccirella S; Salmaso S; Montomoli E
    Vaccine; 2010 Apr; 28(20):3558-62. PubMed ID: 20307592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroepidemiological study of influenza A (H1N1) pdm09 virus following the 2009-2010 wave in Shandong Province, China.
    Liu T; Li Z; Song S; Zhang S; Wang Y; Wang L; Xu A; Wang X; Bi Z
    Scand J Infect Dis; 2013 Jul; 45(7):552-6. PubMed ID: 23672510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A lower than expected adult Victorian community attack rate for pandemic (H1N1) 2009.
    Grills N; Piers LS; Barr I; Vaughan LM; Lester R; Magliano DJ; Shaw JE; Carnie JA
    Aust N Z J Public Health; 2010 Jun; 34(3):228-31. PubMed ID: 20618261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of influenza A pandemic (H1N1) 2009 variants during the first 2009 influenza outbreak in Mexico City.
    Zepeda HM; Perea-Araujo L; Zarate-Segura PB; Vázquez-Pérez JA; Miliar-García A; Garibay-Orijel C; Domínguez-López A; Badillo-Corona JA; López-Orduña E; García-González OP; Villaseñor-Ruíz I; Ahued-Ortega A; Aguilar-Faisal L; Bravo J; Lara-Padilla E; García-Cavazos RJ
    J Clin Virol; 2010 May; 48(1):36-9. PubMed ID: 20226730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral load and epidemiological profile of patients infected by pandemic influenza a (H1N1) 2009 and seasonal influenza a virus in Southern Brazil.
    Gorini da Veiga AB; Kretzmann NA; Corrêa LT; Goshiyama AM; Baccin T; Ardenghi P; Matias F; Gregianini TS; Alves d'Azevedo P
    J Med Virol; 2012 Mar; 84(3):371-9. PubMed ID: 22246821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of public health measures in mitigating pandemic influenza spread: a prospective sero-epidemiological cohort study.
    Lee V; Yap J; Cook AR; Chen M; Tay J; Barr I; Kelso A; Tan B; Loh JP; Lin R; Cui L; Kelly PM; Leo Y; Chia K; Kang WL; Tambyah P; Seet B
    J Infect Dis; 2010 Nov; 202(9):1319-26. PubMed ID: 20863233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological characteristics, clinical presentation and diagnosis at point-of-care during the first wave of the H1N1 influenza pandemic in Cambodia.
    Yasuda C; Sovann L; Kasper M; Williams M; Wierzba TF
    Southeast Asian J Trop Med Public Health; 2012 Jan; 43(1):68-77. PubMed ID: 23082556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of the dynamics and severity of the pandemic A(H1N1) influenza virus on Réunion island, 2009.
    D'Ortenzio E; Renault P; Jaffar-Bandjee MC; Gaüzère BA; Lagrange-Xélot M; Fouillet A; Poubeau P; Winer A; Bourde A; Staikowsky F; Morbidelli P; Rachou E; Thouillot F; Michault A; Filleul L
    Clin Microbiol Infect; 2010 Apr; 16(4):309-16. PubMed ID: 20121825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida--November-December, 2009.
    Cox CM; Goodin K; Fisher E; Dawood FS; Hamilton JJ; Leparc GF; Gray M; Nelson L; Borse RH; Singleton JA; Reed C; Balish AL; Katz JM; Hopkins RS; Fry AM
    PLoS One; 2011; 6(12):e29301. PubMed ID: 22206008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High titers of hemagglutination inhibition antibodies against 2009 H1N1 influenza virus in Southern Iran.
    Moghadami M; Moattari A; Tabatabaee HR; Mirahmadizadeh A; Rezaianzadeh A; Hasanzadeh J; Ebrahimi M; Zamiri N; Alborzi A; Bagheri Lankarani K
    Iran J Immunol; 2010 Mar; 7(1):39-48. PubMed ID: 20371918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing infection by pandemic influenza A(H1N1)pdm09 over three epidemic waves in Singapore.
    Chen MI; Cook AR; Lim WY; Lin R; Cui L; Barr IG; Kelso A; Chow VT; Leo YS; Hsu JP; Shaw R; Chew S; Yap JK; Phoon MC; Koh HW; Zheng H; Tan L; Lee VJ
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1380-9. PubMed ID: 23829633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Seroepidemiologic survey for A/PR/8/34 (H1N1) virus from Chinese residents].
    Guo Y; Qi J; Wang M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Sep; 12(3):223-5. PubMed ID: 12526320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations.
    Veguilla V; Hancock K; Schiffer J; Gargiullo P; Lu X; Aranio D; Branch A; Dong L; Holiday C; Liu F; Steward-Clark E; Sun H; Tsang B; Wang D; Whaley M; Bai Y; Cronin L; Browning P; Dababneh H; Noland H; Thomas L; Foster L; Quinn CP; Soroka SD; Katz JM
    J Clin Microbiol; 2011 Jun; 49(6):2210-5. PubMed ID: 21471339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A community-based study of subclinical flavivirus infections in children in an area of Tamil Nadu, India, where Japanese encephalitis is endemic.
    Gajanana A; Thenmozhi V; Samuel PP; Reuben R
    Bull World Health Organ; 1995; 73(2):237-44. PubMed ID: 7743596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory‐confirmed secondary attack rates and evidence of asymptomatic infections.
    Papenburg J; Baz M; Hamelin MÈ; Rhéaume C; Carbonneau J; Ouakki M; Rouleau I; Hardy I; Skowronski D; Roger M; Charest H; De Serres G; Boivin G
    Clin Infect Dis; 2010 Nov; 51(9):1033-41. PubMed ID: 20887206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot study of seroprevalence of influenza virus type A in Vellore, south India.
    Michael JS; Sridharan G
    Indian J Med Res; 2002 May; 115():173-5. PubMed ID: 12362555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological evidence of subclinical transmission of the 2009 pandemic H1N1 influenza virus outside of Mexico.
    Chao DY; Cheng KF; Li TC; Wu TN; Chen CY; Tsai CA; Chen JH; Chiu HT; Lu JJ; Su MC; Liao YH; Chan WC; Hsieh YH
    PLoS One; 2011 Jan; 6(1):e14555. PubMed ID: 21267441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pandemic influenza A(H1N1)pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009.
    Mörner A; Bråve A; Kling AM; Kühlmann-Berenzon S; Krook K; Hedenskog M; Silhammar I; Ljungman M; Ortqvist A; Andersson S; Brytting M; Thorstensson R; Linde A
    PLoS One; 2012; 7(12):e53511. PubMed ID: 23285299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France.
    Bone A; Guthmann JP; Assal A; Rousset D; Degeorges A; Morel P; Valette M; Enouf V; Jacquot E; Pelletier B; Le Strat Y; Pillonel J; Fonteneau L; van der Werf S; Lina B; Tiberghien P; Lévy-Bruhl D
    PLoS One; 2012; 7(3):e33056. PubMed ID: 22457734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of antibodies to 2009 pandemic influenza A (H1N1) virus in German adult population in pre- and post-pandemic period.
    Dudareva S; Schweiger B; Thamm M; Höhle M; Stark K; Krause G; Buda S; Haas W
    PLoS One; 2011; 6(6):e21340. PubMed ID: 21701598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.